News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
332,954 Results
Type
Article (19981)
Company Profile (128)
Press Release (312845)
Section
Business (105383)
Career Advice (879)
Deals (18537)
Drug Delivery (97)
Drug Development (50779)
Employer Resources (79)
FDA (7687)
Job Trends (7745)
News (185885)
Policy (17333)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (5)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (733)
Accelerated approval (1)
Adcomms (17)
Allergies (40)
Alliances (27828)
ALS (52)
Alzheimer's disease (625)
Antibody-drug conjugate (ADC) (87)
Approvals (7702)
Artificial intelligence (132)
Autoimmune disease (11)
Automation (4)
Bankruptcy (177)
Best Places to Work (5555)
BIOSECURE Act (13)
Biosimilars (94)
Biotechnology (57)
Bladder cancer (30)
Brain cancer (18)
Breast cancer (104)
Cancer (1003)
Cardiovascular disease (106)
Career advice (711)
Career pathing (20)
CAR-T (53)
Cell therapy (147)
Cervical cancer (5)
Clinical research (42598)
Collaboration (442)
Compensation (147)
Complete response letters (23)
COVID-19 (1097)
CRISPR (21)
C-suite (141)
Cystic fibrosis (56)
Data (1058)
Decentralized trials (2)
Denatured (18)
Depression (24)
Diabetes (137)
Diagnostics (1807)
Digital health (5)
Diversity (7)
Diversity, equity & inclusion (21)
Drug discovery (74)
Drug pricing (108)
Drug shortages (30)
Duchenne muscular dystrophy (57)
Earnings (38979)
Editorial (29)
Employer branding (10)
Employer resources (73)
Events (48481)
Executive appointments (415)
FDA (8238)
Featured Employer (23)
Friedreich's ataxia (3)
Frontotemporal dementia (1)
Funding (299)
Gene editing (45)
Generative AI (17)
Gene therapy (141)
GLP-1 (576)
Government (1831)
Grass and pollen (2)
Guidances (18)
Healthcare (5904)
Huntington's disease (13)
IgA nephropathy (19)
Immunology and inflammation (78)
Indications (17)
Infectious disease (1174)
Inflammatory bowel disease (82)
Inflation Reduction Act (8)
Influenza (22)
Intellectual property (52)
Interviews (116)
IPO (7367)
IRA (45)
Job creations (2433)
Job search strategy (648)
Kidney cancer (7)
Labor market (21)
Layoffs (272)
Leadership (13)
Legal (4113)
Liver cancer (31)
Lung cancer (152)
Lymphoma (82)
Machine learning (2)
Management (30)
Manufacturing (189)
MASH (46)
Medical device (1975)
Medtech (1978)
Mergers & acquisitions (11404)
Metabolic disorders (472)
Multiple sclerosis (46)
NASH (20)
Neurodegenerative disease (43)
Neuropsychiatric disorders (20)
Neuroscience (915)
NextGen: Class of 2025 (2359)
Non-profit (906)
Northern California (1027)
Now hiring (20)
Obesity (295)
Opinion (189)
Ovarian cancer (33)
Pain (65)
Pancreatic cancer (35)
Parkinson's disease (78)
Partnered (11)
Patents (130)
Patient recruitment (45)
Peanut (16)
People (33386)
Pharmaceutical (74)
Pharmacy benefit managers (21)
Phase I (13334)
Phase II (18023)
Phase III (14480)
Pipeline (660)
Podcasts (68)
Policy (101)
Postmarket research (1618)
Preclinical (4647)
Press Release (29)
Prostate cancer (58)
Psychedelics (16)
Radiopharmaceuticals (162)
Rare diseases (230)
Real estate (3170)
Recruiting (29)
Regulatory (12495)
Reports (22)
Research institute (818)
Resumes & cover letters (138)
Rett syndrome (1)
RNA editing (2)
RSV (24)
Schizophrenia (58)
Series A (55)
Series B (31)
Service/supplier (6)
Sickle cell disease (35)
Southern California (988)
Special edition (15)
Spinal muscular atrophy (111)
Sponsored (12)
Startups (2008)
State (2)
Stomach cancer (9)
Supply chain (49)
The Weekly (47)
United States (9650)
Vaccines (264)
Venture capitalists (27)
Webinars (11)
Weight loss (233)
Women's health (14)
Worklife (7)
Date
Today (121)
Last 7 days (388)
Last 30 days (1407)
Last 365 days (17119)
2025 (4156)
2024 (17679)
2023 (19638)
2022 (25870)
2021 (26645)
2020 (24874)
2019 (20063)
2018 (15595)
2017 (17257)
2016 (16202)
2015 (18804)
2014 (14788)
2013 (12553)
2012 (13484)
2011 (13818)
2010 (12739)
Location
Africa (408)
Alabama (22)
Alaska (1)
Arizona (63)
Arkansas (8)
Asia (24854)
Australia (3208)
California (2405)
Canada (1067)
China (311)
Colorado (94)
Connecticut (96)
Delaware (68)
Europe (51288)
Florida (414)
Georgia (52)
Idaho (16)
Illinois (235)
India (18)
Indiana (168)
Iowa (3)
Japan (111)
Kansas (60)
Kentucky (17)
Louisiana (1)
Maine (4)
Maryland (353)
Massachusetts (2022)
Michigan (46)
Minnesota (132)
Mississippi (1)
Missouri (26)
Montana (10)
Nebraska (11)
Nevada (15)
New Hampshire (8)
New Jersey (975)
New Mexico (21)
New York (700)
North Carolina (484)
North Dakota (2)
Northern California (1027)
Ohio (80)
Oklahoma (5)
Oregon (21)
Pennsylvania (567)
Puerto Rico (10)
Rhode Island (13)
South America (606)
South Carolina (3)
Southern California (988)
Tennessee (38)
Texas (319)
Utah (53)
Virginia (78)
Washington D.C. (41)
Washington State (207)
Wisconsin (19)
332,954 Results for "eip pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) today announced that its stockholders have voted to approve all proposals at a special meeting of stockholders held earlier today, including the issuance of Diffusion Common Stock in the pending merger with EIP Pharma Inc. (“EIP”), and a reverse stock split of outstanding Diffusion Common Stock (the “Reverse Split”).
August 15, 2023
·
6 min read
Deals
CervoMed Announces Completion of Merger with EIP Pharma
CervoMed Inc. (formerly known as Diffusion Pharmaceuticals Inc.) (NASDAQ: CRVO), now a clinical-stage company focused on developing treatments for degenerative diseases of the brain, today announced the closing of its previously announced merger with EIP Pharma Inc.
August 16, 2023
·
9 min read
Business
Poolbeg Pharma PLC Announces Board Role Change and Launch of EIP
Poolbeg Pharma announces a change of Board role and the Remuneration Committee’s approval of the adoption of an Employee Performance Incentive Plan for a number of the key senior management, to align medium and long term objectives with those of shareholders and to encourage retention.
February 15, 2024
·
13 min read
Genetown
EIP Pharma to Present at Canaccord Genuity 43rd Annual Growth Conference
EIP Pharma Inc., a clinical stage company focused on developing treatments for neurodegenerative diseases, announced that the Company’s senior management team will present at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, August 9 at 4:00 p.m. ET.
August 3, 2023
·
4 min read
Clinical research
Pharma R&D Returns Grow Again, But Deloitte Warns Progress is ‘Fragile’
Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.
March 27, 2025
·
3 min read
·
Annalee Armstrong
Drug Development
EIP Pharma Announces First Patient Dosed in RewinD-LB Phase 2b Clinical Trial Evaluating Neflamapimod in Dementia with Lewy Bodies
EIP Pharma Inc. today announced that the first patient has been dosed in the Company’s RewinD-LB Phase 2b clinical trial of neflamapimod for the treatment of patients with dementia with Lewy bodies (DLB).
August 14, 2023
·
12 min read
Genetown
EIP Pharma to Present at JMP Securities Life Sciences Conference 2023
EIP Pharma Inc., a clinical stage company focused on developing treatments for neurodegenerative diseases, announced that the Company’s senior management team will present at the JMP Securities Life Sciences Conference on Monday, May 15 at 11:00 a.m. ET.
May 11, 2023
·
4 min read
Government
Trump Threatens Big Pharma With Tariffs—Unless They Reshore Manufacturing: Bloomberg
President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.
February 24, 2025
·
2 min read
·
Tristan Manalac
C-suite
GSK CEO Emma Walmsley Gets Pay Bump To Align With Pharma Peers
One of the lowest paid CEOs in pharma—and one of the only woman leading a top-tier giant—is set to receive up to $27.2 million in 2025.
February 27, 2025
·
2 min read
·
Annalee Armstrong
Business
EIP Pharma and Diffusion Pharmaceuticals Announce Merger Agreement to Create Leading CNS-focused Company Treating Neurodegenerative Diseases
EIP Pharma Inc. and Diffusion Pharmaceuticals Inc., announced that the companies have entered into a definitive merger agreement for an all-stock transaction forming a publicly traded, combined company that will focus on the advancement of EIP Pharma’s pioneering pipeline of oral stress kinase inhibitors, including its lead drug candidate neflamapimod, which is currently being developed for the treatment of dementia with Lewy bodies.
March 30, 2023
·
14 min read
1 of 33,296
Next